$LFT
Lument Finance Trust, Inc. Stock $lft

$lft Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000162828023038670 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$32.48M	$31.86M
YoY Change	68.46%	116.02%
Cost Of Revenue	$23.39M	$22.31M
YoY Change	88.71%	140.79%
Gross Profit	$9.093M	$9.540M
YoY Change	32.02%	73.99%
Gross Profit Margin	27.99%	29.94%
Selling, General & Admin	$2.595M	$2.280M
YoY Change	4.91%	-11.49%
% of Gross Profit	28.54%	23.9%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$4.068M	$3.240M
YoY Change	-17.5%	-22.5%
Operating Profit	$5.025M	$6.300M
YoY Change	156.82%	383.67%
Interest Expense	-$56.33K	$0.00
YoY Change	153.17%	-100.0%
% of Operating Profit	-1.12%	0.0%
Other Income/Expense, Net
YoY Change
Pretax Income	$5.010M	$6.380M
YoY Change	138.96%	354.97%
Income Tax	-$4.060K	$19.80K
% Of Pretax Income	-0.08%	0.31%
Net Earnings	$3.829M	$6.360M
YoY Change	335.21%	323.9%
Net Earnings / Revenue	11.79%	19.96%
Basic Earnings Per Share		$0.10
Diluted Earnings Per Share	$0.07	$0.10
COMMON SHARES
Basic Shares Outstanding	52.23M shares	52.23M shares
Diluted Shares Outstanding		52.23M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$51.25M	$43.40M
YoY Change	16.85%	-10.49%
Cash & Equivalents	$51.25M	$43.41M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$59.84M	$83.10M
YoY Change	20.5%	55.77%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$270.1K	$6.200M
YoY Change	-92.3%	-78.03%
Total Long-Term Assets	$1.387B	$1.360B
YoY Change	28.64%	26.5%
TOTAL ASSETS
Total Short-Term Assets	$59.84M	$83.10M
Total Long-Term Assets	$1.387B	$1.360B
Total Assets	$1.447B	$1.443B
YoY Change	28.28%	27.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$4.093M	$3.800M
YoY Change	73.36%	128.62%
Deferred Revenue
YoY Change
Short-Term Debt	$1.146B	$1.145B
YoY Change	38.21%	38.21%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.157B	$1.155B
YoY Change	38.01%	38.09%
LONG-TERM LIABILITIES
Long-Term Debt	$47.22M	$47.20M
YoY Change	0.53%	0.62%
Other Long-Term Liabilities	$2.374M	$400.0K
YoY Change	306.45%	7.3%
Total Long-Term Liabilities	$49.59M	$47.60M
YoY Change	5.58%	1.47%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.157B	$1.155B
Total Long-Term Liabilities	$49.59M	$47.60M
Total Liabilities	$1.206B	$1.203B
YoY Change	36.3%	36.15%
SHAREHOLDERS EQUITY
Retained Earnings	$47.37M	$42.36M
YoY Change	51.59%	45.14%
Common Stock	$522.5K	$522.3K
YoY Change	0.04%	0.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$240.7M	$240.5M
YoY Change
Total Liabilities & Shareholders Equity	$1.447B	$1.443B
YoY Change	28.28%	27.88%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	$3.829M	$6.360M
YoY Change	335.21%	323.9%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$9.225M	$5.420M
YoY Change	102.64%	57.5%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$2.537M	-$365.1M
YoY Change	-91.42%	-1364.56%
Cash From Investing Activities	-$2.537M	-$365.1M
YoY Change	-91.42%	-1364.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-4.805M	309.6M
YoY Change	11.16%	-7274.31%
NET CHANGE
Cash From Operating Activities	9.225M	5.420M
Cash From Investing Activities	-2.537M	-365.1M
Cash From Financing Activities	-4.805M	309.6M
Net Change In Cash	1.883M	-50.13M
YoY Change	-106.42%	-279.03%
FREE CASH FLOW
Cash From Operating Activities	$9.225M	$5.420M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2400000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52231152	shares
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	791563	usd
CY2022Q3	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	1521023	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	1166962	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	1872937	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	4243884	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4243884	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2023Q1	oaks	Cost Of Issuing Of Common Stock Values CostOfIssuingOfCommonStockValues	14040	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	3358	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	5766691	usd
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	3133869	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1184958	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	240847239	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	13620	usd
CY2023Q2	oaks	Cost Of Issuing Of Common Stock Values CostOfIssuingOfCommonStockValues	14196	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	-10784	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-176343	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	2574227	usd
CY2023Q2	us-gaap	Dividends Common Stock DividendsCommonStock	3133869	usd
CY2023Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1185042	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	239091195	usd
CY2023Q3	oaks	Cost Of Issuing Of Common Stock Values CostOfIssuingOfCommonStockValues	14352	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	6359727	usd
CY2023Q3	us-gaap	Dividends Common Stock DividendsCommonStock	3656181	usd
CY2023Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1185042	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	240595347	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	169375500	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	83468443	usd
CY2022Q1	oaks	Cost Of Issuing Of Common Stock Values CostOfIssuingOfCommonStockValues	2404070	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	4638	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2954799	usd
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	3133509	usd
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1184958	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	249080843	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	18810	usd
CY2022Q2	oaks	Cost Of Issuing Of Common Stock Values CostOfIssuingOfCommonStockValues	14196	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	-14334	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	3343852	usd
CY2022Q2	us-gaap	Dividends Common Stock DividendsCommonStock	3133869	usd
CY2022Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1185042	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	248096064	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
CY2022Q3	oaks	Cost Of Issuing Of Common Stock Values CostOfIssuingOfCommonStockValues	14352	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	3433	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	1500275	usd
CY2022Q3	us-gaap	Dividends Common Stock DividendsCommonStock	3133869	usd
CY2022Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1185042	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	245266509	usd
	us-gaap	Net Income Loss NetIncomeLoss	14700645	usd
	us-gaap	Net Income Loss NetIncomeLoss	7798926	usd
	oaks	Accretion Of Discounts On Held For Investment Loans AccretionOfDiscountsOnHeldForInvestmentLoans	431009	usd
	oaks	Accretion Of Discounts On Held For Investment Loans AccretionOfDiscountsOnHeldForInvestmentLoans	125098	usd
	oaks	Amortization Of Premiums On Held For Investment Loans AmortizationOfPremiumsOnHeldForInvestmentLoans	16201	usd
	oaks	Amortization Of Premiums On Held For Investment Loans AmortizationOfPremiumsOnHeldForInvestmentLoans	55804	usd
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	195022	usd
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	0	usd
	oaks	Amortization Of Offering Costs AmortizationOfOfferingCosts	-42588	usd
	oaks	Amortization Of Offering Costs AmortizationOfOfferingCosts	-100219	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2302706	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2072877	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	1166962	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	1872937	usd
	oaks	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	-47350	usd
	oaks	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	265910	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	6194	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	12547	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	2809908	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	281273	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	272085	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	310623	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1472032	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	958090	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-242236	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-205860	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	224987	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	15513382	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11736702	usd
	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	517608525	usd
	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	269596827	usd
	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	203425029	usd
	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	247335751	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-314183496	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-22261076	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	81136045	usd
	oaks	Proceeds From Collateralized Loan Obligations And Secured Financings ProceedsFromCollateralizedLoanObligationsAndSecuredFinancings	317700000	usd
	oaks	Proceeds From Collateralized Loan Obligations And Secured Financings ProceedsFromCollateralizedLoanObligationsAndSecuredFinancings	0	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	3809453	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	119375	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	9401607	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	8512687	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	3551250	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	3551250	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	300937690	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	68952733	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2267576	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	58428359	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47366365	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18279052	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49633941	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	76707411	usd
	us-gaap	Interest Paid Net InterestPaidNet	47634719	usd
	us-gaap	Interest Paid Net InterestPaidNet	17383416	usd
	oaks	Dividends Declared Not Yet Paid DividendsDeclaredNotYetPaid	4657473	usd
	oaks	Dividends Declared Not Yet Paid DividendsDeclaredNotYetPaid	4135161	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The financial statements have been prepared on the accrual basis of accounting in accordance with GAAP. The preparation of financial statements in conformity with GAAP requires the Company to make a number of significant estimates. These include estimates of fair value of certain assets and liabilities, amount and timing of credit losses, prepayment rates, and other estimates that affect the reported amounts of certain assets and liabilities as of the date of the financial statements and the reported amounts of certain revenues and expenses during the reported period. It is likely that changes in these estimates (e.g. valuation changes due to supply and demand, credit performance, prepayments, interest rates, or other reasons) will occur in the near term. The Company's estimates are inherently subjective in nature and actual results could differ from its estimates and the differences may be material.</span></div>
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43408581	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43858515	usd
CY2023Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	6225360	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3507850	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49633941	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47366365	usd
CY2023Q3	oaks	Number Of Realized Loan Losses Since Inception NumberOfRealizedLoanLossesSinceInception	1	realizedloanloss
CY2023Q3	oaks	Number Of Commercial Real Estate Loans Included In Loan Performance Analytical Model NumberOfCommercialRealEstateLoansIncludedInLoanPerformanceAnalyticalModel	100000	loan
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1076148186	usd
CY2022Q4	us-gaap	Allowance For Loan And Lease Losses Real Estate AllowanceForLoanAndLeaseLossesRealEstate	4258668	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	1071889518	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	583989	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	31250852	usd
CY2023Q3	oaks	Number Of Sub Servers NumberOfSubServers	2	sub-servicer
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52231152	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52231152	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52231152	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52231152	shares
CY2015Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	10000000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2400000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2400000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2400000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2400000	shares
CY2023Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	4716230	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	4258668	usd
CY2023Q3	us-gaap	Financing Receivable Unamortized Purchase Premium Discount FinancingReceivableUnamortizedPurchasePremiumDiscount	-7023177	usd
CY2022Q4	oaks	One Month Libor Rate OneMonthLIBORRate	0.0418
CY2023Q3	oaks	One Month Sofr Rate OneMonthSOFRRate	0.0533
CY2022Q4	oaks	One Month Sofr Rate OneMonthSOFRRate	0.0419
CY2023Q3	oaks	Weighted Average Libor Floor Rate WeightedAverageLIBORFloorRate	0.0041
CY2022Q4	oaks	Weighted Average Libor Floor Rate WeightedAverageLIBORFloorRate	0.0027
CY2023Q3	oaks	Weighted Average Floating Rate WeightedAverageFloatingRate	1.000
CY2022Q4	oaks	Weighted Average Floating Rate WeightedAverageFloatingRate	0.774
CY2022Q4	oaks	Weighted Average Sofr Rate WeightedAverageSOFRRate	0.226
CY2023Q3	oaks	Average Risk Rate AverageRiskRate	3.4
CY2022Q4	oaks	Average Risk Rate AverageRiskRate	3.0
CY2023Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	6000000	usd
CY2022	oaks	Reserve For Impaired Loan ReserveForImpairedLoan	4300000	usd
CY2021Q2	oaks	Number Of Newly Formed Subsidiaries NumberOfNewlyFormedSubsidiaries	2	subsidiary
CY2021Q2	oaks	Variable Interest Entity Qualitative And Quantitative Information Equity Interest VariableInterestEntityQualitativeAndQuantitativeInformationEquityInterest	96250000	usd
CY2021Q2	oaks	Proceeds From Issuance Of Debt Securities Allocated To Acquire Additional Loan Obligations ProceedsFromIssuanceOfDebtSecuritiesAllocatedToAcquireAdditionalLoanObligations	330300000	usd
CY2021Q2	oaks	Period To Acquire Additional Loan Obligations From Closing Date PeriodToAcquireAdditionalLoanObligationsFromClosingDate	P180D
CY2021Q2	oaks	Collateralized Loan Obligation Leverage Ratio CollateralizedLoanObligationLeverageRatio	0.83
CY2023Q3	us-gaap	Financing Receivable Unamortized Purchase Premium Discount FinancingReceivableUnamortizedPurchasePremiumDiscount	-7023177	usd
CY2022Q4	oaks	One Month Libor Rate OneMonthLIBORRate	0.0418
CY2023Q3	oaks	One Month Sofr Rate OneMonthSOFRRate	0.0533
CY2022Q4	oaks	One Month Sofr Rate OneMonthSOFRRate	0.0419
CY2023Q3	oaks	Weighted Average Libor Floor Rate Collateralized Loan Obligations WeightedAverageLIBORFloorRateCollateralizedLoanObligations	0.0041
CY2022Q4	oaks	Weighted Average Libor Floor Rate Collateralized Loan Obligations WeightedAverageLIBORFloorRateCollateralizedLoanObligations	0.0025
CY2023Q3	oaks	Financing Receivable Sofr Spread Rate FinancingReceivableSOFRSpreadRate	0.0356
CY2022Q4	oaks	Financing Receivable Sofr Spread Rate FinancingReceivableSOFRSpreadRate	0.0341
	us-gaap	Loans Receivable Basis Spread On Variable Rate During Period LoansReceivableBasisSpreadOnVariableRateDuringPeriod	0.0199
CY2022	us-gaap	Loans Receivable Basis Spread On Variable Rate During Period LoansReceivableBasisSpreadOnVariableRateDuringPeriod	0.0143
CY2019Q1	oaks	Collateralized Loan Obligation Unamortized Discount CollateralizedLoanObligationUnamortizedDiscount	39200000	usd
CY2023Q3	oaks	Collateralized Loan Obligation Deferred Financing Costs CollateralizedLoanObligationDeferredFinancingCosts	592582	usd
CY2022Q4	oaks	Collateralized Loan Obligation Deferred Financing Costs CollateralizedLoanObligationDeferredFinancingCosts	778958	usd
CY2023Q3	us-gaap	Secured Debt SecuredDebt	47750000	usd
CY2023Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	47750000	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	47750000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	47750000	usd
CY2023Q3	us-gaap	Secured Debt SecuredDebt	47750000	usd
CY2023Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	47750000	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	47750000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	47750000	usd
CY2023Q3	oaks	Number Of Sub Servers NumberOfSubServers	2	sub-servicer
CY2023Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	748307	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	795656	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	1071889518	usd
	oaks	Annual Management Fee Percentage AnnualManagementFeePercentage	0.015
	oaks	Quarterly Management Fee Percentage QuarterlyManagementFeePercentage	0.00375
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52231152	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52231152	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52231152	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52231152	shares
CY2023Q2	oaks	Fair Market Value Average Closing Prices Share Of Common Stock Reported Nyse Period FairMarketValueAverageClosingPricesShareOfCommonStockReportedNYSEPeriod	10	tradingday
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	6359727	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	1500275	usd
CY2023Q3	us-gaap	Dividends Common Stock DividendsCommonStock	3656181	usd
CY2022Q3	us-gaap	Dividends Common Stock DividendsCommonStock	3133869	usd
CY2023Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1185042	usd
CY2022Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1185042	usd
CY2023Q3	us-gaap	Dividends Dividends	4841223	usd
CY2022Q3	us-gaap	Dividends Dividends	4318911	usd
CY2023Q3	us-gaap	Undistributed Earnings UndistributedEarnings	1518504	usd
CY2022Q3	us-gaap	Undistributed Earnings UndistributedEarnings	-2818636	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52231152	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52225152	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	6000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52231152	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52231152	shares
	us-gaap	Net Income Loss NetIncomeLoss	14700645	usd
	us-gaap	Net Income Loss NetIncomeLoss	7798926	usd
	us-gaap	Dividends Common Stock DividendsCommonStock	9923919	usd
	us-gaap	Dividends Common Stock DividendsCommonStock	9401247	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3555042	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3555042	usd
	us-gaap	Dividends Dividends	13478961	usd
	us-gaap	Dividends Dividends	12956289	usd
	us-gaap	Undistributed Earnings UndistributedEarnings	1221684	usd
	us-gaap	Undistributed Earnings UndistributedEarnings	-5157363	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52227504	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47026745	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3648	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	5088	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52231152	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47031833	shares

Files In Submission

Name	View Source	Status
0001628280-23-038670-index-headers.html	Edgar Link	pending
0001628280-23-038670-index.html	Edgar Link	pending
0001628280-23-038670.txt	Edgar Link	pending
0001628280-23-038670-xbrl.zip	Edgar Link	pending
a20230930exhibit31-1.htm	Edgar Link	pending
a20230930exhibit31-2.htm	Edgar Link	pending
a20230930exhibit32-1.htm	Edgar Link	pending
a20230930exhibit32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
oaks-20230930.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
oaks-20230930.xsd	Edgar Link	pending
oaks-20230930_g1.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
oaks-20230930_def.xml	Edgar Link	unprocessable
oaks-20230930_lab.xml	Edgar Link	unprocessable
oaks-20230930_pre.xml	Edgar Link	unprocessable
oaks-20230930_htm.xml	Edgar Link	completed
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
oaks-20230930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LFT
Lument Finance Trust, Inc. Stock $lft

2023 Q4 Form 10-Q Financial Statement

#000162828023038670 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFT Lument Finance Trust, Inc. Stock $lft

2023 Q4 Form 10-Q Financial Statement

#000162828023038670 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFT
Lument Finance Trust, Inc. Stock $lft